These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 21699487)

  • 1. Anti-Inflammatory properties of antipsychotics via microglia modulations: are antipsychotics a 'fire extinguisher' in the brain of schizophrenia?
    Kato TA; Monji A; Mizoguchi Y; Hashioka S; Horikawa H; Seki Y; Kasai M; Utsumi H; Kanba S
    Mini Rev Med Chem; 2011 Jun; 11(7):565-74. PubMed ID: 21699487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risperidone significantly inhibits interferon-gamma-induced microglial activation in vitro.
    Kato T; Monji A; Hashioka S; Kanba S
    Schizophr Res; 2007 May; 92(1-3):108-15. PubMed ID: 17363222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Redox and microglia in the pathophysiology of schizophrenia].
    Kato TA; Hyodo F; Yamato M; Utsumi H; Kanba S
    Yakugaku Zasshi; 2015; 135(5):739-43. PubMed ID: 25948311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretreatment of aripiprazole and minocycline, but not haloperidol, suppresses oligodendrocyte damage from interferon-γ-stimulated microglia in co-culture model.
    Seki Y; Kato TA; Monji A; Mizoguchi Y; Horikawa H; Sato-Kasai M; Yoshiga D; Kanba S
    Schizophr Res; 2013 Dec; 151(1-3):20-8. PubMed ID: 24100191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aripiprazole inhibits superoxide generation from phorbol-myristate-acetate (PMA)-stimulated microglia in vitro: implication for antioxidative psychotropic actions via microglia.
    Kato TA; Monji A; Yasukawa K; Mizoguchi Y; Horikawa H; Seki Y; Hashioka S; Han YH; Kasai M; Sonoda N; Hirata E; Maeda Y; Inoguchi T; Utsumi H; Kanba S
    Schizophr Res; 2011 Jul; 129(2-3):172-82. PubMed ID: 21497059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroinflammation in schizophrenia especially focused on the role of microglia.
    Monji A; Kato TA; Mizoguchi Y; Horikawa H; Seki Y; Kasai M; Yamauchi Y; Yamada S; Kanba S
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Apr; 42():115-21. PubMed ID: 22192886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effects of aripiprazole on interferon-gamma-induced microglial activation via intracellular Ca2+ regulation in vitro.
    Kato T; Mizoguchi Y; Monji A; Horikawa H; Suzuki SO; Seki Y; Iwaki T; Hashioka S; Kanba S
    J Neurochem; 2008 Jul; 106(2):815-25. PubMed ID: 18429930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical antipsychotics: mechanism of action.
    Seeman P
    Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the anti-dopamine D₂ and anti-serotonin 5-HT(2A) activities of chlorpromazine, bromperidol, haloperidol and second-generation antipsychotics parent compounds and metabolites thereof.
    Suzuki H; Gen K; Inoue Y
    J Psychopharmacol; 2013 Apr; 27(4):396-400. PubMed ID: 23427194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis.
    Kapur S; Seeman P
    Am J Psychiatry; 2001 Mar; 158(3):360-9. PubMed ID: 11229973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipsychotics, chlorpromazine and haloperidol inhibit voltage-gated proton currents in BV2 microglial cells.
    Shin H; Song JH
    Eur J Pharmacol; 2014 Sep; 738():256-62. PubMed ID: 24990667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extrastriatal and striatal D(2) dopamine receptor blockade with haloperidol or new antipsychotic drugs in patients with schizophrenia.
    Xiberas X; Martinot JL; Mallet L; Artiges E; Loc'H C; Mazière B; Paillère-Martinot ML
    Br J Psychiatry; 2001 Dec; 179():503-8. PubMed ID: 11731352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Concepts in Dopamine D
    Urs NM; Peterson SM; Caron MG
    Biol Psychiatry; 2017 Jan; 81(1):78-85. PubMed ID: 27832841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Antipsychotic Drugs: Cross Talk Between the Nervous and Innate Immune System.
    Dinesh AA; Islam J; Khan J; Turkheimer F; Vernon AC
    CNS Drugs; 2020 Dec; 34(12):1229-1251. PubMed ID: 32975758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antipsychotic spiperone attenuates inflammatory response in cultured microglia via the reduction of proinflammatory cytokine expression and nitric oxide production.
    Zheng LT; Hwang J; Ock J; Lee MG; Lee WH; Suk K
    J Neurochem; 2008 Dec; 107(5):1225-35. PubMed ID: 18786164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokines and schizophrenia: Microglia hypothesis of schizophrenia.
    Monji A; Kato T; Kanba S
    Psychiatry Clin Neurosci; 2009 Jun; 63(3):257-65. PubMed ID: 19579286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuronal injury, but not microglia activation, is associated with ketamine-induced experimental schizophrenic model in mice.
    Hou Y; Zhang H; Xie G; Cao X; Zhao Y; Liu Y; Mao Z; Yang J; Wu C
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():107-16. PubMed ID: 23603358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding antipsychotic "atypicality": a clinical and pharmacological moving target.
    Remington G
    J Psychiatry Neurosci; 2003 Jul; 28(4):275-84. PubMed ID: 12921222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between subjective well-being and dopamine D2 receptors in patients treated with a dopamine partial agonist and full antagonist antipsychotics.
    Mizrahi R; Mamo D; Rusjan P; Graff A; Houle S; Kapur S
    Int J Neuropsychopharmacol; 2009 Jun; 12(5):715-21. PubMed ID: 19366489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aripiprazole inhibits polyI:C-induced microglial activation possibly via TRPM7.
    Sato-Kasai M; Kato TA; Ohgidani M; Mizoguchi Y; Sagata N; Inamine S; Horikawa H; Hayakawa K; Shimokawa N; Kyuragi S; Seki Y; Monji A; Kanba S
    Schizophr Res; 2016 Dec; 178(1-3):35-43. PubMed ID: 27614570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.